Egypt: EBRD, DPI and CDC create US$750m biopharmaceutical platform

The European Bank for Reconstruction and Development (EBRD), private equity firm Development Partners International (DPI) and impact investor the CDC Group have joined forces to create a US$750m investment platform to invest in pharmaceuticals. They have committed an initial US$250m to fund the acquisition and combination of Adwia Pharmaceuticals, an Egyptian generic drugs manufacturer, and…

You must be a HMI Subscriber to view this content.

Subscribe Now »